CBFP
IBB icon

Cedar Brook Financial Partners’s iShares Biotechnology ETF IBB Stock Holding History

Cedar Brook Financial Partners’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-7,426
Closed -$1.02M – 192
2024
Q1 		$1.02M Buy
7,426
+483
+7% +$66K 0.2% 121
2023
Q4 		$950K Buy
6,943
+3,451
+99% +$421K 0.21% 119
2023
Q3 		$427K Buy
3,492
+733
+27% +$93.2K 0.11% 189
2023
Q2 		$350K Buy
2,759
+58
+2% +$7.53K 0.08% 250
2023
Q1 		$349K Buy
2,701
+195
+8% +$25.5K 0.09% 242
2022
Q4 		$329K Buy
+2,506
New +$324K 0.09% 250

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Cedar Brook Financial Partners's IBB Position: Q2 2024 in Review

Cedar Brook Financial Partners sold out of iShares Biotechnology ETF (IBB) in Q2 2024, closing a stake of 7,426 shares — an estimated $1.02M sold.

Cedar Brook Financial Partners first reported a position in IBB in Q4 2022 and held it in 6 quarters. The position peaked at $1.02M in Q1 2024. 896 funds tracked by Wall St. Rank hold IBB as of Q2 2024.

  • Cedar Brook Financial Partners reported no remaining iShares Biotechnology ETF position as of Q2 2024 after selling out during the quarter.
  • Cedar Brook Financial Partners sold 7,426 iShares Biotechnology ETF shares in Q2 2024, an estimated $1.02M.
  • Cedar Brook Financial Partners first reported a position in iShares Biotechnology ETF in Q4 2022 and held it in 6 quarters.
  • Cedar Brook Financial Partners's iShares Biotechnology ETF position peaked at $1.02M in Q1 2024.
  • 896 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2024.

Based on Cedar Brook Financial Partners's 13F filing for Q2 2024, filed 15 Jul 2024.